Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14885821 | 0.92 | TSHR (0.38) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL15893236 | 0.90 | TSHR (0.46) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL69828 | 0.82 | TSHR (0.43) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL69507 | 0.81 | TSHR (0.33) | TSHRALDH1A1HSD17B10GAAKMT2A | |
| Suxemerid SCHEMBL2779070 | 0.81 | SMN1; SMN2 (0.39) | TSHRALDH1A1TP53HSD17B10MEN1 | |
| SCHEMBL69450 | 0.81 | TSHR (0.35) | TSHRHPGDALDH1A1TP53HIF1A | |
| Ethylene SCHEMBL11193217 | 0.79 | TSHR (0.33) | TSHRALDH1A1HSD17B10GAAKMT2A | |
| SCHEMBL15893238 | 0.79 | TSHR (0.35) | TSHR | |
| SCHEMBL8849439 | 0.78 | TSHR (0.42) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL15893239 | 0.78 | TSHR (0.35) | TSHRHPGDALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160122643-A1 | METHOD OF INHIBITING POLYMERIZATION AND FOULING IN ACRYLIC ACID AND ACRYLATE PROCESSES | ARKEMA INC. (US) | 2016-05-05 | — | — | US | disclosed |
| EP-2070998-B1 | Inkjet recording ink composition and inkjet recording method | FUJIFILM CORP (JP) | 2015-04-08 | — | — | EP | disclosed |
| US-20130178652-A1 | METHOD OF INHIBITING POLYMERIZATION AND FOULING IN ACRYLIC ACID AND ACRYLATE PROCESSES | ARKEMA INC. (US) | 2013-07-11 | — | — | US | disclosed |
| US-8128843-B2 | Photocurable composition, photocurable ink composition, process for producing photocured material, and inkjet recording method | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8128843-B2 | Photocurable composition, photocurable ink composition, process for producing photocured material, and inkjet recording method | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8092869-B2 | Ink composition for ink jet recording and method for ink jet recording | FUJIFILM CORPORATION (JP) | 2012-01-10 | — | — | US | disclosed |
| US-8092869-B2 | Ink composition for ink jet recording and method for ink jet recording | FUJIFILM CORPORATION (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20110160484-A1 | Method of Inhibiting Polymerization and Fouling in Acrylic Acid and Acrylate Processes | ARKEMA INC. | 2011-06-30 | — | — | US | disclosed |
| EP-2085439-A1 | Photocurable composition, photocurable ink composition, process for producing photocured material, and inkjet recording method | FUJIFILM Corporation (JP) | 2009-08-05 | — | — | EP | disclosed |
| US-20090186163-A1 | PHOTOCURABLE COMPOSITION, PHOTOCURABLE INK COMPOSITION, PROCESS FOR PRODUCING PHOTOCURED MATERIAL, AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090186163-A1 | PHOTOCURABLE COMPOSITION, PHOTOCURABLE INK COMPOSITION, PROCESS FOR PRODUCING PHOTOCURED MATERIAL, AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090155484-A1 | Inkjet recording ink composition and inkjet recording method | FUJIFILM CORPORATION (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090155484-A1 | Inkjet recording ink composition and inkjet recording method | FUJIFILM CORPORATION (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090074982-A1 | INK COMPOSITION FOR INK JET RECORDING AND METHOD FOR INK JET RECORDING | FUJIFILM CORPORATION (JP) | 2009-03-19 | — | — | US | disclosed |
| US-20090074982-A1 | INK COMPOSITION FOR INK JET RECORDING AND METHOD FOR INK JET RECORDING | FUJIFILM CORPORATION (JP) | 2009-03-19 | — | — | US | disclosed |
| US-20080131618-A1 | INK COMPOSITION FOR INKJET-RECORDING AND METHOD FOR INKJET-RECORDING | FUJIFILM CORPORATION (JP) | 2008-06-05 | — | — | US | disclosed |
| US-20080131618-A1 | INK COMPOSITION FOR INKJET-RECORDING AND METHOD FOR INKJET-RECORDING | FUJIFILM CORPORATION (JP) | 2008-06-05 | — | — | US | disclosed |
| EP-1927477-A1 | Ink composition for inkjet-recording and method for inkjet-recording | FUJIFILM Corporation (JP) | 2008-06-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130178652-A1 | METHOD OF INHIBITING POLYMERIZATION AND FOULING IN ACRYLIC ACID AND ACRYLATE PROCESSES | AOC2, HAO2, AOC3 | TSHR 4193/4885HPGD 325/4885ALDH1A1 221/4885 |
| US-20110160484-A1 | Method of Inhibiting Polymerization and Fouling in Acrylic Acid and Acrylate Processes | HAO2, AOC2, HACL2 | TSHR 4006/4885HPGD 452/4885ALDH1A1 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.